Nutrien Dirección
Dirección controles de criterios 3/4
El CEO de Nutrien es Ken Seitz , nombrado en Jan 2022, tiene una permanencia de 4.33 años. compensación anual total es $9.44M, compuesta por 9.3% salario y 90.7% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.01% de las acciones de la empresa, por valor de CA$4.68M. La antigüedad media del equipo directivo y de la junta directiva es de 1 años y 8.3 años, respectivamente.
Información clave
Ken Seitz
Chief Executive Officer (CEO)
US$9.4m
Compensación total
| Porcentaje del salario del CEO | 9.28% |
| Permanencia del CEO | 4.3yrs |
| Participación del CEO | 0.01% |
| Permanencia media de la dirección | 1yrs |
| Promedio de permanencia en la Junta Directiva | 8.3yrs |
Actualizaciones recientes de la dirección
Recent updates
Actualización de narrativa • May 20
NTR: Tighter Fertilizer Markets And DOJ Probe Will Guide Future Returns
Analysts have trimmed the fair value estimate for Nutrien to CA$92.08 from CA$95.15, reflecting slightly lower revenue and margin assumptions, even as recent research points to mixed price target changes across the Street. Analyst Commentary Recent Street research presents a mixed picture, with some firms lifting price targets and ratings while others trim expectations or shift to a more cautious stance.Actualización de narrativa • May 03
NTR: Tighter Fertilizer Markets And DOJ Probe Will Shape Future Returns
The updated analyst price target for Nutrien reflects a small decrease of about CA$0.26. Analysts are balancing slightly softer implied revenue growth and a marginally higher discount rate against firmer profit margin assumptions and a modestly lower future P/E multiple.
Actualización de narrativa • Apr 19
NTR: Tighter Fertilizer Markets And DOJ Probe Will Shape Balanced Outlook
The analyst price target for Nutrien has risen by CA$4.18. Analysts attribute this change to updated assumptions for slightly stronger revenue growth, higher profit margins, and a lower future P/E multiple, reflecting the recent wave of higher sector targets and tighter global fertilizer markets.Actualización de narrativa • Apr 04
NTR: Tighter Fertilizer Markets And DOJ Probe Will Pressure Future Returns
Analysts have nudged the fair value estimate for Nutrien higher to CA$95.41. This reflects a modestly lower discount rate, slightly firmer long term margin assumptions, and updated sector P/E comparisons that incorporate a wave of recent price target increases tied to tighter fertilizer markets and higher commodity pricing expectations.Actualización de narrativa • Mar 21
NTR: Higher Fertilizer Pricing And DOJ Probe Will Shape Share Performance
Analysts have lifted the average Nutrien price target by roughly CA$31 to around CA$95, citing stronger fertilizer pricing, higher expected profit margins and support for elevated sector valuation multiples, despite more cautious views on volume growth. Analyst Commentary Recent research on Nutrien largely centers on fertilizer pricing, geopolitical risks and the earnings impact of tighter nitrogen and potash markets.Actualización de narrativa • Mar 07
NTR: Nutrient Pricing, Portfolio Actions And DOJ Probe Will Shape Balanced Outlook
The analyst price target for Nutrien has increased to CA$101.07 from CA$96.56, as analysts factor in firmer nutrient pricing expectations, potential nitrogen upside tied to recent geopolitical events, and company-specific portfolio actions that they view as supportive of earnings stability and cash generation. Analyst Commentary Recent research points to a broadly constructive tone around Nutrien, with multiple firms updating models after the Q4 report and adjusting price targets on the back of nutrient pricing assumptions, portfolio moves, and expected cash generation.Actualización de narrativa • Feb 21
NTR: Firmer Nutrient Pricing And Potash Supply Risks Will Shape Balanced Returns
Our updated fair value estimate for Nutrien edges higher to CA$96.56 from CA$91.99, reflecting a series of analyst price target increases tied to refreshed models after recent results, stronger assumed profit margins, and expectations that nutrient pricing holds firmer for longer, even as some remain cautious about future potash supply. Analyst Commentary Street research on Nutrien has been active, with several firms revisiting their models and adjusting price targets around recent and upcoming quarterly results.Actualización de narrativa • Feb 07
NTR: Reassessed P/E And Farm Headwinds Will Shape Balanced Returns Ahead
Analysts have raised our Nutrien fair value estimate to $91.99 from $88.43, as recent price target increases and rating changes suggest a reassessment of the stock's risk profile, growth outlook, and appropriate future P/E multiple. Analyst Commentary Recent Street research on Nutrien has become more constructive, with several firms increasing price targets or improving ratings while others remain cautious on end market conditions and sector headwinds.
Actualización de narrativa • Jan 23
NTR: Higher Fertilizer Pricing And Buybacks Will Support Future Upside
Our analyst price target for Nutrien edges slightly lower to about $112.49 from $113.03, as analysts weigh mixed sector commentary on fertilizer and agriculture markets against recent target adjustments and an updated future P/E assumption of roughly 20.2x. Analyst Commentary Recent Street research on Nutrien reflects mixed sector views but a generally supportive tone on the company, with several bullish analysts adjusting targets and ratings while acknowledging a more cautious backdrop for fertilizers and agriculture.Actualización de narrativa • Jan 09
NTR: Fertilizer Cycle Concerns Will Pressure Shares Despite Recent Buybacks
Narrative Update Analysts have nudged their consolidated price target for Nutrien down by about $2 to $64. This reflects updated views that factor in more cautious fertilizer and agriculture setups, modestly lower assumed revenue growth, a slightly higher profit margin profile, and a reduced future P/E multiple in their models.Actualización de narrativa • Dec 21
NTR Is Expected To Benefit From Potential Upside In Fertilizer Pricing
Analysts have modestly reduced their price target on Nutrien to approximately $113 from about $97, citing a tougher near term backdrop for farmers, slightly lower growth and margin expectations, and a more balanced risk reward profile after the stock's strong run. Analyst Commentary Recent Street research reflects a mixed but generally constructive stance on Nutrien, with several firms trimming price targets modestly while maintaining positive ratings.Actualización de narrativa • Dec 07
NTR: Portfolio Streamlining And Farm Headwinds Will Shape Balanced Returns Ahead
Analysts have modestly reduced their price expectations for Nutrien, trimming the target by a low single digit dollar amount to reflect a tougher near term farm income backdrop, portfolio streamlining impacts, and a more balanced risk reward view despite solid recent execution. Analyst Commentary Street research on Nutrien reflects a constructive long term view, tempered by nearer term caution around farm fundamentals, commodity pricing and the impact of recent portfolio moves.Actualización de narrativa • Nov 23
NTR: Portfolio Streamlining And Asset Sales Will Drive Sector Outperformance Ahead
Nutrien's analyst price target has been modestly reduced by $0.21 to $88.43. Analysts cite ongoing sector headwinds, including weaker crop prices, portfolio adjustments, and a more balanced risk-reward outlook, despite solid recent performance.Actualización de narrativa • Nov 07
NTR: Portfolio Streamlining and Supply Tightness Will Shape Upside Amid Sector Scrutiny
Nutrien’s average analyst price target has edged slightly lower in recent weeks, as analysts weigh a modestly improving profit margin and fair value estimate against easing revenue growth and persistent caution over the agricultural cycle. Analyst Commentary Recent analyst activity around Nutrien highlights both opportunities and challenges for the company as it navigates ongoing market volatility and shifting sector dynamics.Actualización de narrativa • Oct 24
Shifting Market Trends Will Shape Fertilizer Demand Amid Agricultural Cycle Uncertainty
Nutrien's analyst price targets have recently edged lower by $1 to $2 per share, as analysts cite cautious earnings expectations, a more balanced risk-reward profile, and the impact of portfolio adjustments on future performance. Analyst Commentary Recent Street research highlights a divided outlook among analysts covering Nutrien, reflecting both positive and cautionary perspectives as the company navigates its next phase of growth and portfolio transformation.Actualización de narrativa • Oct 09
Global Food Demand And Precision Ag Will Secure Fertilizer Success
Analysts have modestly raised their price target for Nutrien, increasing it by approximately $1.38 to reflect updated earnings projections and evolving outlooks for fertilizer market conditions. Analyst Commentary Recent street research reflects a mixed outlook on Nutrien's growth trajectory, valuation, and near-term execution capacity.Artículo de análisis • Sep 08
With Nutrien Ltd. (TSE:NTR) It Looks Like You'll Get What You Pay For
Nutrien Ltd.'s ( TSE:NTR ) price-to-earnings (or "P/E") ratio of 20.1x might make it look like a sell right now...Artículo de análisis • Aug 08
Nutrien Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Shareholders might have noticed that Nutrien Ltd. ( TSE:NTR ) filed its second-quarter result this time last week. The...Artículo de análisis • Jul 16
Nutrien (TSE:NTR) Has Some Way To Go To Become A Multi-Bagger
What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...Artículo de análisis • Jul 03
A Look At The Fair Value Of Nutrien Ltd. (TSE:NTR)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Nutrien fair value estimate is CA$98.09 Current share price of...
Nueva narrativa • Feb 09
Accelerated Efficiency And Expanded Potash And Nitrogen Output Will Strengthen Future Operations
Accelerated operational efficiency and strategic sales expansion may enhance margins and boost revenue without significant new capital expenditure.Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | US$2b |
| Dec 31 2025 | US$9m | US$876k | US$2b |
| Sep 30 2025 | n/a | n/a | US$2b |
| Jun 30 2025 | n/a | n/a | US$1b |
| Mar 31 2025 | n/a | n/a | US$527m |
| Dec 31 2024 | US$8m | US$863k | US$674m |
| Sep 30 2024 | n/a | n/a | US$733m |
| Jun 30 2024 | n/a | n/a | US$790m |
| Mar 31 2024 | n/a | n/a | US$845m |
| Dec 31 2023 | US$7m | US$852k | US$1b |
| Sep 30 2023 | n/a | n/a | US$2b |
| Jun 30 2023 | n/a | n/a | US$4b |
| Mar 31 2023 | n/a | n/a | US$7b |
| Dec 31 2022 | US$9m | US$829k | US$8b |
| Sep 30 2022 | n/a | n/a | US$8b |
| Jun 30 2022 | n/a | n/a | US$7b |
| Mar 31 2022 | n/a | n/a | US$4b |
| Dec 31 2021 | US$4m | US$677k | US$3b |
| Sep 30 2021 | n/a | n/a | US$2b |
| Jun 30 2021 | n/a | n/a | US$964m |
| Mar 31 2021 | n/a | n/a | US$621m |
| Dec 31 2020 | US$5m | US$596k | US$459m |
| Sep 30 2020 | n/a | n/a | US$95m |
| Jun 30 2020 | n/a | n/a | US$823m |
| Mar 31 2020 | n/a | n/a | US$916m |
| Dec 31 2019 | US$3m | US$137k | US$992m |
Compensación vs. Mercado: La compensación total ($USD9.44M) de Ken está en línea con el promedio de empresas de tamaño similar en el mercado Canadian ($USD7.97M).
Compensación vs. Ingresos: La compensación de Ken ha sido consistente con los resultados de la empresa en el último año.
CEO
Ken Seitz (55 yo)
4.3yrs
Permanencia
US$9,437,234
Compensación
Mr. Kenneth A. Seitz, also known as Ken, is Director of The Fertilizer Institute. Mr. Seitz is Chief Executive Officer, Non-Independent Director and President of Nutrien Ltd. from August 8, 2022.He served...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 4.3yrs | US$9.44m | 0.0099% CA$ 4.7m | |
| Executive VP & CFO | 1.8yrs | US$3.56m | 0.0075% CA$ 3.5m | |
| Executive VP of External Affairs | 6.3yrs | US$3.25m | 0.0036% CA$ 1.7m | |
| Executive Vice President of Global Sales | less than a year | US$2.82m | 0.0022% CA$ 1.0m | |
| Vice President of Investor Relations | no data | sin datos | sin datos | |
| Executive VP of Corporate Development & Chief Strategy Officer | 4.3yrs | sin datos | 0.0017% CA$ 789.2k | |
| Executive VP of IT & Chief People Officer | 1.9yrs | sin datos | sin datos | |
| Head Economist | no data | sin datos | sin datos | |
| Senior Vice President of Safety | less than a year | sin datos | sin datos | |
| Senior Vice President of Upstream | less than a year | sin datos | sin datos | |
| Senior Vice President of Midstream | less than a year | sin datos | sin datos | |
| Senior Vice President of Upstream | less than a year | sin datos | 0.0014% CA$ 661.6k |
1.0yrs
Permanencia media
Equipo directivo experimentado: El equipo directivo de NTR no se considera experimentado ( 1 años antigüedad media), lo que sugiere un nuevo equipo.
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 3.8yrs | US$9.44m | 0.0099% CA$ 4.7m | |
| Independent Director | 8.3yrs | US$300.00k | 0.0011% CA$ 515.1k | |
| Independent Chairman | 8.3yrs | US$550.00k | 0.0029% CA$ 1.4m | |
| Independent Director | 5yrs | US$300.00k | 0.00012% CA$ 56.7k | |
| Independent Director | 8.3yrs | US$325.00k | 0.0080% CA$ 3.8m | |
| Non-Independent Director | 8.3yrs | US$300.00k | 0.0012% CA$ 571.8k | |
| Independent Director | 4yrs | US$316.21k | 0.0010% CA$ 491.5k | |
| Independent Director | 8.3yrs | US$308.79k | 0.00021% CA$ 99.2k | |
| Independent Director | no data | sin datos | sin datos | |
| Independent Director | 8.3yrs | US$325.00k | 0.0035% CA$ 1.7m | |
| Independent Director | 5.8yrs | US$300.00k | 0.00017% CA$ 80.3k | |
| Independent Director | 8.3yrs | US$325.00k | 0.0014% CA$ 647.4k |
8.3yrs
Permanencia media
62.5yo
Promedio de edad
Junta con experiencia: La junta directiva de NTR se considera experimentada (8.3 años de antigüedad promedio).
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/05/20 13:26 |
| Precio de las acciones al final del día | 2026/05/20 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Nutrien Ltd. está cubierta por 52 analistas. 15 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Harriet Li | Accountability Research Corporation |
| Keith Carpenter | ATB Cormark |
| Benjamin Theurer | Barclays |